Research
Size:
Share:

ERM US 101 – Sponsored by Notal Vision, Inc.

Active Study | Duration: 12 months

ERM US 101 is a new study being conducted to compare the output of the ForeseeHome device in detecting and monitoring metamorphopsia (distortion) due to an epiretinal membrane (ERM). The study will also work to predict the degree of distortion following surgery. The device is currently FDA approved to monitor the development of choroidal neovascularization in patients with wet AMD. This study is for patients 21 years of age and older with a diagnosis of epiretinal membrane. Participants will be monitored for 12 months.

This study is currently enrolling in our Rockville office (600 Jefferson Plaza, Suite 320) under the direction of Clinical Research Coordinator Keith Wolsieffer (301-315-2198 / kwolsieffer@rgw.com), and our Chevy Chase office (5454 Wisconsin Ave, Suite 650) under the direction of Clinical Research Coordinator Maya Talatory (301-656-8100 / mtalatory@rgw.com).

Return to Other Studies